Next point of interest is the AGM next week - the last shareholder quarterly referred to external facilitation of a strategic review towards a lead candidate for clinical trial (I read that as we are off the dirt road and onto bitumen with the highway in sight) - most likely completed by now and ready for release. These things don't contain sensitive stuff but will hopefully answer a lot of andrew65 & peaceakkis questions on focus/strategy on top of the recent unveiling of pretty exciting progress that only seems to be heard in our little bubble.
Might form a core piece of investor marketing over the next 6-12 months.
PYC Price at posting:
1.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)